OpenVSafe by OpenVAERS
Search V-safe

6S6-33468-84658

1 vaccination 3 coded responses 13 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
0-4
ZIP prefix
598 / MT
Registered
2022-09-12
Relationship
Child or adolescent in my care
Guardian
H2L-14457-74774
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-09-12
    Registered in v-safe
  2. 2022-09-12
    Dose 1 — Pfizer-BioNTech
    Co-administered: Do not remember
  3. 2022-09-12
    Health check-in — day 0, dose 1, under 3
    Feeling: Fair · Sleepiness
    Under 3 check-in
  4. 2022-09-14
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  5. 2022-09-16
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  6. 2022-09-17
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · Irritability/crying
    Under 3 check-in
  7. 2022-09-18
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · Irritability/crying
    Under 3 check-in
  8. 2022-09-19
    Health check-in — day 7, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  9. 2022-09-26
    Survey response — day 14, dose 1, under 3
    MedDRA: Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Fever for 48 hours
    MedDRA releases: 2024-11 · check-in free text available
  10. 2022-10-03
    Health check-in — day 21, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  11. 2022-10-10
    Health check-in — day 28, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  12. 2022-10-19
    Survey response — day 35, dose 1, under 3
    MedDRA: Nasopharyngitis — Feeling: Fair
    Free text: Cold symptoms
    MedDRA releases: 2024-11 · check-in free text available
  13. 2022-10-24
    Health check-in — day 42, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  14. 2022-12-12
    Health check-in — 3 months, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  15. 2023-03-13
    Survey response — 6 months, dose 1, under 3
    MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  16. 2023-03-13
    Report sent to call center — 6 months, dose 1, under 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  17. 2023-03-14

Vaccinations

DoseDateManufacturerCo-administered
12022-09-12Pfizer-BioNTech Do not remember

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 12 (Under 3) — day 14, dose 1, under 3

2022-09-26

Symptoms: Fever for 48 hours

Release 12 (Under 3) — day 35, dose 1, under 3

2022-10-19

Symptoms: Cold symptoms

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDNasopharyngitis · · ✓
SDPyrexia · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…